Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia

Lilly

Status and phase: Completed; Phase 4

Conditions: Schizophrenia

Treatments: Drug: Olanzapine

Study type: Interventional

Funder types: Industry

Identifiers

NCT00036088

2347

F1D-MC-HGHJ

Details and patient eligibility

About

The purpose of this study is to determine how Olanzapine compares to an active comparator in the treatment of schizophrenia

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion:

1. You must be between the ages of 18 and 75. If you have reached your 76th birthday, you will not be able to participate
2. You must have been diagnosed with schizophrenia
3. You must be able to visit the doctor's office as scheduled for the next 7 months

Exclusion:

1. You have a serious medical illness, such as heart, liver, or kidney disease (Note: If you are uncertain about a particular condition, discuss it with your doctor.)
2. You are either pregnant or breastfeeding

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind